Update date
30 Sep 2019
Shareable Research Card
This metric view shows MBIO - MUSTANG BIO, INC. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported operating margin: 83624%. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
30 Sep 2019
Page type
Metric history
Latest period
Q3 2019
SEC-backed company facts were refreshed from filings filed on 19 Mar 2026.
Benchmark Context
MUSTANG BIO, INC. sits in the top quarter of the current operating margin sample.
Compared with
Compared with 120 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 471.1x the current sample midpoint. Operating Margin does not yet have enough prior-period data for a historical comparison on this page.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Latest period: Q3 2019. Period end: 30 Sep 2019. Units: %. Frequency: quarterly.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
MUSTANG BIO, INC. appears at rank #5 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (gwso) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | NAMI Corp. | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 3 | PharmaCyte Biotech, Inc. (pmcb) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 4 | ALR Technologies SG Ltd. (alrtf) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 5 | MUSTANG BIO, INC. (mbio) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
| 6 | DOMINION ENERGY SOUTH CAROLINA, INC. | 63100% | Quarter - 31 Dec 2020 | Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q3 2019 | 83624% | +153830% | 01 Jul 2019 | 30 Sep 2019 | |
| Q2 2019 | 78944% | +148006% | 01 Apr 2019 | 30 Jun 2019 | |
| Q1 2019 | 69000% | +138912% | 01 Jan 2019 | 31 Mar 2019 | |
| Q3 2018 | -70206% | 01 Jul 2018 | 30 Sep 2018 | ||
| Q2 2018 | -69062% | 01 Apr 2018 | 30 Jun 2018 | ||
| Q1 2018 | -69912% | 01 Jan 2018 | 31 Mar 2018 |